Navigation Links
China BCT Signs Exclusive Distribution Contract With Liujiang County Chinese Medicine Hospital

LIUZHOU CITY, China, June 30 /PRNewswire-Asia-FirstCall/ -- China BCT Pharmacy Group, Inc., (OTC Bulletin Board: CNBI), ("China BCT" or the "Company"), a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced that the Company signed an exclusive pharmaceutical distribution contract with Liujiang County Chinese Medicine Hospital for a three-year period effective July 1, 2010.

China BCT will supply a minimum of 95% of all pharmaceutical products required by Liujiang County Chinese Medicine Hospital, covering approximately 500 products while maintaining priority rights to supply the remaining 5% of products. China BCT management estimates that this distribution arrangement will generate approximately $1 million in annual revenue.

"This contract signifies our brand's considerable strength within Guangxi Province and will strengthen our gross margins," commented Mr. Hui Tian Tang, Chairman and Chief Executive Officer of China BCT. "Liujiang County Chinese Medicine Hospital will increase its efficiency by streamlining purchasing processes through our exclusive distribution agreement. We target to win more exclusive distribution contracts for our wholesale distribution business, as expansion of this segment is one of our key business strategies and growth drivers to maintain healthy and sustainable profit margin."

About China BCT

China BCT is engaged in pharmaceutical distribution, pharmacy retailing, and the manufacture of pharmaceuticals products through its subsidiaries Guangxi Liuzhou Baicaotang Medicine Limited, Hefeng Pharmaceutical Co. Limited, and Guangxi Liuzhou Baicaotang Medicine Retail Limited in Guangxi province, China. It operates a large regional retail network in Guangxi province, consisting of 125 directly owned retail stores in Guangxi province and currently over 8,000 products are distributed through the Company's wholesale distribution network. For more information, please visit http://www.china-

Safe Harbor Statement

This presentation contains "forward-looking statements" within the meaning of the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that could cause the actual results of the Company to differ materially from the results expressed or implied by such statements, including the significance of the appointment of the new directors. Accordingly, although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company has no obligation to update the forward-looking information contained in this presentation.

    For more information, please contact:

    Company Contact:
     Ms. Shelly Zhang, Chief Financial Officer
     China BCT Pharmacy Group, Inc.
     Tel:   +86-772-363-8318

    Investor Relations Contact:

    CCG Investor Relations
     Mr. Crocker Coulson, President
     CCG Investor Relations
     Tel:   +1-646-213-1915

     Mr. Shaun Smolarz
     Financial Writer
     Tel:   +1-646-701-7444

SOURCE China BCT Pharmacy Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Medical Technologies Announces the Recent Publication of a Study on its SPR Analyzer and HPV DNA Chip in Cancer Genetics and Cytogenetics and the Creation of a Medical Publications Column to the Investor Relations Section on its Website
2. VacChina 2010 - A Premium Event to Define the Vaccine Industry in Asia
3. Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration
4. Diagnostic Imaging Markets in Brazil, Russia, India, China (BRIC) 2010 - 2015: MarketsandMarkets
5. Emerging Markets (BRIC - Brazil, Russia, India and China): Patient Monitors 2010 - 2014
6. China Medical Technologies Reports Financial Results for Fourth Fiscal Quarter and Full Year ended March 31, 2010
7. China Sky One Medicals Subsidiaries Recognized as Provincial Model Companies
8. Reportlinker Adds China Patient Monitoring Market Outlook to 2016
9. China BCT Acquires 11 Stores, Expanding Retail Pharmacy Network
10. Reportlinker Adds China Cardiovascular Devices Market Outlook to 2016
11. China Yongxin Pharmaceuticals Announces 1-for-12 Reverse Stock Split
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... As part ... For Empowerment ™ attracts volunteers together who want to combine talents and resources ... key stakeholders in the process. The non-profit launched its first major fundraiser on ...
(Date:11/25/2015)... ... 25, 2015 , ... Finnleo, a leader in the traditional and far-infrared sauna ... and far-infrared saunas. , For traditional saunas, Finnleo is offering 20% ... wood, and Finnleo uses only European Grade A Nordic White Spruce from sustainably grown ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... sauna parts and accessories. , Sauna accessories help improve the bather experience in ... personality. From basic styles for the purist looking for simplicity in design to ...
(Date:11/25/2015)... ... 26, 2015 , ... Ministers, senior government and UN agencies, ... Centres of Excellence, and public R&D institutions, civil societies and other partners gathered ... 5th African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The three- ...
(Date:11/25/2015)... ... 2015 , ... For the first time, Vitalalert is donating half of its ... The partnership between the two groups began in 2014 with Vitalalert pledging a portion ... International was founded in 1954 and is an international Christian-based health organization whose mission ...
Breaking Medicine News(10 mins):